- Differential diagnosis of neuromyelitis optica spectrum disorders2020 | First Faculty of Medicine
- Neuromyelitis optica spectrum disorders - new treatment options2020 | First Faculty of Medicine
- The use of optical coherence tomography in neuromyelitis optica spectrum disorders2020 | First Faculty of Medicine
- Clinical and therapeutic predictors of disease outcomes in AQP4-IgG + neuromyelitis optica spectrum disorder2020 | First Faculty of Medicine
- History of neuromyelitis optica spectrum disorders, development of the diagnostic criteria2020 | First Faculty of Medicine
- Epidemiology, clinical manifestation, and disease course of neuromyelitis optica spectrum disorders2020 | Second Faculty of Medicine
- Magnetic resonance imaging findings in neuromyelitis optica spectrum disorders and disease associated with antibodies to myelin oligodendrocyte glycoprotein2022 | First Faculty of Medicine
- Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia2021 | First Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Sex bias in multiple sclerosis and neuromyelitis optica spectrum disorders: How it influences clinical course, MRI parameters and prognosis2022 | First Faculty of Medicine
- Neuromyelitis optica spectrum disorders - specifics in children2020 | Second Faculty of Medicine
- Neuromyelitis optica spectrum disorders - laboratory examination2020 | First Faculty of Medicine
- Long-term therapy and symptomatic treatment of neuromyelitis optica spectrum disorders2020 | First Faculty of Medicine
- Magnetic resonance imaging in neuromyelitis optica spectrum disorders2020 | First Faculty of Medicine
- Neuromyelitis Optica Spectrum Disorders - Retrospective Analysis of Clinical and Paraclinical Findings2015 | First Faculty of Medicine
- Neuromyelitis optica2015 | First Faculty of Medicine
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Ocular manifestations of disease associated with the presence of antibodies to myelin oligodendrocyte glycoprotein2023 | Central Library of Charles University
- Pathological magnetic resonance imaging findings in myelin oligodendrocyte glycoprotein antibody-associated disease2022 | First Faculty of Medicine
- MS and NMOSD during the pandemic COVID-19 - what have we already learnt?2021 | First Faculty of Medicine, Faculty of Physical Education and Sport
- MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T2016 | First Faculty of Medicine
- Diagnosis and classification of optic neuritis2022 | First Faculty of Medicine
- Evoked potentials in neuromyelitis optica and neuromyelitis optica spectrum disroders2020 | First Faculty of Medicine
- Acute pediatric myelitis - cohort of 20 patients2018 | First Faculty of Medicine, Second Faculty of Medicine
- Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica2016 | First Faculty of Medicine
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection2022 | First Faculty of Medicine